跳至主要内容
临床试验/NCT00483002
NCT00483002已完成不适用

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

Pfizer0 个研究点目标入组 3,719 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Pfizer
入组人数
3,719
主要终点
Percentage of Participants With 7-day Point Prevalence From Week 3 to Less Than Week 7

研究概览

简要总结

To monitor use in real practice including safety and efficacy of Champix tablets 0.5mg, 1mg medication for 12 weeks in smokers

详细描述

No sampling method will be applied to this study.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects selected for this study are those who would have been prescribed Champix tablets by the physician according to the subject's condition in usual clinical practice.

排除标准

  • 未提供

研究组 & 干预措施

Healthy smokers

干预措施: varenicline (Drug)

结局指标

主要结局

Percentage of Participants With 7-day Point Prevalence From Week 3 to Less Than Week 7

时间窗: Week 3 through Week 7

Treatment effectiveness was measured by 7-day point prevalence of smoking abstinence status. The smoking status was categorized as smoking or abstained smoking based on 2 parameters: if participant smoked any cigarettes (even a puff) in the last 7 days (Yes/No); if participant used any other nicotine-containing products in the last 7 days (Yes/No).

Percentage of Participants With 7-day Point Prevalence From Week 7 to Less Than Week 11

时间窗: Week 7 through Week 11

Treatment effectiveness was measured by 7-day point prevalence of smoking abstinence status. The smoking status was categorized as smoking or abstained smoking based on 2 parameters: if participant smoked any cigarettes (even a puff) in the last 7 days (Yes/No); if participant used any other nicotine-containing products in the last 7 days (Yes/No).

Percentage of Participants With 7-day Point Prevalence for at Least Week 11

时间窗: At least Week 11

Treatment effectiveness was measured by 7-day point prevalence of smoking abstinence status. The smoking status was categorized as smoking or abstained smoking based on 2 parameters: if participant smoked any cigarettes (even a puff) in the last 7 days (Yes/No); if participant used any other nicotine-containing products in the last 7 days (Yes/No).

次要结局

未报告次要终点

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

相似试验